Alveolar Soft Part Sarcoma
📧 Sign up to get email alerts when something new happens for Alveolar Soft Part Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg [Phase 2]
Phase 2 trial evaluating pembrolizumab plus local chemotherapy delivered by isolated limb infusion for patients with sarcoma in the arm or l…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of Benmelstobart Injection and Anlotinib hydrochloride capsules for advanced or unresect…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing [Phase 1]
Phase 1 clinical trial investigating therapeutic drug monitoring-based dosing of atezolizumab across multiple cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma [Phase 2]
Phase 2 clinical trial evaluating atezolizumab alone or with bevacizumab for alveolar soft-part sarcoma; the study is currently active but n…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours [Phase 1]
Phase 1 trial of GCAR1 CAR T-cell therapy for GPNMB-expressing solid tumors; study targets alveolar soft-part sarcoma, renal cell carcinoma,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial [Phase 2]
This is a Phase 2 clinical trial (AXIOM) sponsored by the National Cancer Institute evaluating atezolizumab plus selinexor for alveolar soft…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02) [EARLY_Phase 1]
An early-phase 1 trial of GCAR1, a GPNMB-targeting CAR T-cell therapy, for alveolar soft part sarcoma; the study is currently active but not…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating alpha/beta T and B cell depletion with zoledronic acid for solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) [Phase 3]
APROMISS is a Phase III trial of combined anlotinib and catequentinib in advanced alveolar soft-part sarcoma, leiomyosarcoma, and synovial s…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group [NA]
An ongoing clinical trial under the MIRAS project aims to perform multimodal immune characterization of rare soft tissue sarcomas and relate…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. [Phase 1]
This Phase 1 trial of FAZ053 as a single agent and in combination with PDR001 in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma [EARLY_Phase 1]
An early-phase clinical trial is evaluating the investigational cellular therapy GCAR1 for alveolar soft part sarcoma, but the study is not …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma [EARLY_Phase 1]
An early-phase trial update reports results of GCAR1, a GPNMB-targeting CAR-T cell therapy, in a patient with alveolar soft part sarcoma.
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma [EARLY_Phase 1]
An early-phase 1 trial of GCAR1 CAR T therapy for relapsed alveolar soft part sarcoma is ongoing, sponsored by the University of Calgary, wi…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: AB122 Platform Study [Phase 1]
Phase 1 AB122 platform study is currently recruiting for advanced or metastatic solid tumors, including pancreatic ductal adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma [Phase 2]
A Phase 2 trial evaluating sunitinib and cediranib for alveolar soft part sarcoma has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: CREATE: Cross-tumoral Phase 2 With Crizotinib [Phase 2]
Phase 2 cross-tumor trial evaluating crizotinib in multiple locally advanced or metastatic cancers; study completed.
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib-s-maleate in pediatric patients with recurrent, refractory, or newly diagnosed sarcomas, Wi…
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas [Phase 2]
Phase 2 trial evaluating axitinib in combination with pembrolizumab in advanced alveolar soft part sarcoma and other soft tissue sarcomas ha…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma [Phase 2]
Phase II trial update reporting results for Cediranib (AZD2171) in alveolar soft part sarcoma; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226) [Phase 2]
Phase 2 clinical trial update in Chinese patients with alveolar soft part sarcoma (GB226).
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS [Phase 2]
Phase 2 trial update investigating carilizumab in combination with apatinib for unresectable undifferentiated pleomorphic sarcoma and alveol…
-
CLINICAL_TRIALS research · 2019-01-24Clinical Trial Update: A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) [Phase 2]
Phase 2 clinical trial evaluating cediranib for alveolar soft-part sarcoma; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas [Phase 2]
Phase 2 trial evaluating perifosine in chemo-insensitive sarcomas, including chondrosarcoma, alveolar soft-part sarcoma, and extraskeletal m…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Pazopanib for Metastatic Alveolar Soft Part Sarcoma [Phase 2]
Phase 2 trial of Pazopanib for metastatic alveolar soft-part sarcoma has been terminated.